• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

(2,3-dimethoxypyridin-4-yl)boronic acid and its significance in modern pharmaceutical research: A deep dive into CAS no. 1031438-93-3

The compound with the CAS number 1031438-93-3, known as (2,3-dimethoxypyridin-4-yl)boronic acid, represents a fascinating and highly versatile building block in the realm of pharmaceutical chemistry. This boronic acid derivative has garnered significant attention due to its unique structural features and its potential applications in the synthesis of novel therapeutic agents. Boronic acids, in general, are renowned for their ability to participate in various chemical reactions, including Suzuki-Miyaura cross-coupling, which is a cornerstone of modern organic synthesis and drug development.

In recent years, the pharmaceutical industry has witnessed a surge in the use of boronic acid derivatives as key intermediates in the development of small-molecule drugs. The presence of both methoxy and boronic acid functional groups in (2,3-dimethoxypyridin-4-yl)boronic acid endows it with exceptional reactivity and adaptability. This compound has been explored in various contexts, from academic research to industrial-scale drug synthesis, underscoring its importance in medicinal chemistry.

The pyridine core of this molecule is particularly noteworthy. Pyridine derivatives are ubiquitous in pharmaceuticals due to their ability to interact with biological targets in a highly specific manner. The substitution pattern at the 2 and 3 positions with methoxy groups enhances the electronic properties of the pyridine ring, making it an ideal candidate for further functionalization. This structural motif has been leveraged to develop molecules with enhanced binding affinity and selectivity towards biological receptors.

One of the most compelling aspects of (2,3-dimethoxypyridin-4-yl)boronic acid is its role in the synthesis of targeted therapies. Boronic acids are particularly well-suited for generating molecules that can undergo site-specific modifications, a critical requirement for many modern drugs. The boronic acid moiety can be readily coupled with aryl halides via Suzuki-Miyaura cross-coupling reactions, allowing for the construction of complex molecular architectures with precision.

Recent studies have highlighted the utility of this compound in the development of kinase inhibitors, which are among the most widely used classes of drugs for treating cancer and inflammatory diseases. The pyridine-boronic acid scaffold can be incorporated into kinase inhibitors to improve their pharmacokinetic properties and reduce off-target effects. For instance, modifications at the 4-position of the pyridine ring have been shown to enhance binding interactions with specific kinase domains, leading to more potent and selective inhibitors.

The versatility of (2,3-dimethoxypyridin-4-yl)boronic acid extends beyond kinase inhibition. Researchers have also explored its potential in developing antiviral and antibacterial agents. The ability to introduce diverse functional groups into the pyridine core allows for fine-tuning of molecular properties such as solubility, metabolic stability, and cell membrane permeability. These factors are crucial for ensuring that therapeutic agents can reach their intended targets effectively.

In addition to its applications in drug discovery, this compound has found utility in materials science and catalysis. The boronic acid functional group participates in a wide range of reactions that make it an excellent tool for designing new catalysts and functional materials. For example, it has been used to develop novel ligands for transition metal catalysis, which are essential for facilitating various organic transformations.

The synthesis of (2,3-dimethoxypyridin-4-yl)boronic acid itself is another area where innovation has been prominent. Modern synthetic methodologies have enabled more efficient and scalable production processes for this compound. Advances in boron chemistry have led to improved methods for handling boronic acids under mild conditions, reducing the need for harsh reagents or high temperatures. These improvements not only enhance yield but also make the process more environmentally friendly.

The future prospects for this compound remain promising as research continues to uncover new applications and refine existing ones. The integration of computational chemistry and machine learning techniques is accelerating the discovery process by predicting how different modifications will affect molecular properties. This interdisciplinary approach is particularly valuable when dealing with complex molecules like those derived from (2,3-dimethoxypyridin-4-yl)boronic acid.

In conclusion, (2,3-dimethoxypyridin-4-yl)boronic acid (CAS no. 1031438-93-3) stands as a testament to the power of specialized molecular building blocks in driving innovation across multiple scientific disciplines. Its unique structural features make it an invaluable tool for pharmaceutical researchers seeking to develop novel therapeutics with improved efficacy and safety profiles. As our understanding of chemical biology continues to evolve, compounds like this one will undoubtedly play an increasingly pivotal role in shaping the future of medicine.

• 1451393-41-1(2-Phenoxypyridine-4-boronic acid)
• 2093406-60-9((2-(pyridin-2-yloxy)phenyl)boronic acid)
• 2096339-93-2(5-Chloro-2,3-dimethoxypyridine-4-boronic acid)
• 1072952-50-1((3-methoxy-4-pyridyl)boronic acid;hydrate)
• 1346526-61-1(5,6-dimethoxypyridin-3-ylboronic acid)
• 1008506-24-8(3-Methoxypyridine-4-boronic acid)
• 1630193-77-9(2,5-Dimethoxypyridine-4-boronic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)